Capital Asset Management Specialist

S&P 500 stock Healthpeak Properties: that's how much loss a Healthpeak Properties investment from 5 years ago would have brought. Aug. 21, 2026, 4:00 p.m. With an early investment in Healthpeak Properties stocks, investors would have suffered such a loss. Today, 5 years ago, the Healthpeak Properties stock was not traded on the NYSE due to the weekend. On the previous trading day, the Healthpeak Properties share closed at $35.16. If an investor had invested $1,000 in Healthpeak Properties stock 5 years ago, they would now own 28.441 shares. Since the value of a share as of August 20, 2026, was $21.20 (closing price), the original investment would now be worth $602.96. This would have reduced the value of the original investment by 39.70 percent. Healthpeak Properties' market capitalization most recently amounted to $14.30 billion. Please note that the above calculation does not take into account stock splits and dividend payments. Editorial staff finanzen.net Selected leveraged products on Healthpeak Properties. With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired leverage and we will show you suitable open-end products on Healthpeak Properties | Name | Leverage | KO | Issuer | | No products with the selected leverage are available for this underlying asset. | Risk warning: On average, 7 out of 10 retail investors lose money when trading turbo certificates. Turbo certificates are highly risky products and are not suitable for long-term investment strategies.

Healthpeak Properties buys St. Augustine, Fla., Senior Living community for $54 million. Healthpeak Properties bought the Allegro Senior Living community in St. Augustine, Fla., for $54 million, adding to the healthcare REIT's senior housing portfolio amid strong sector-wide investor demand. Healthpeak Properties, the Denver-based, S&P 500 healthcare REIT, has bought the Allegro Senior Living community in St. Augustine, Fla., for $54 million, according to a July 31 report from the Jacksonville Daily Record. The 102,786-square-foot assisted living and memory care facility sits at 1101 Plantation Drive S. The seller was KAPG St. Augustine Senior Housing OpCo LLC, a St. Louis-based entity that had been the legally registered owner and licensee of the Allegro brand at the property, the Daily Record reported. Following the sale, the community no longer appears on Allegro Living's online portfolio of communities, and the property's dedicated website and phone number have been taken offline - signs the facility is being transitioned to new branding or management under its new owner. Healthpeak, founded in 1985, owns, operates and develops healthcare-focused real estate nationally, including medical office buildings, life-science campuses and senior housing communities. The St. Augustine purchase adds to a senior housing portfolio the company has been building alongside its office and lab holdings, as healthcare REITs broadly have leaned into senior living and outpatient medical assets as a growth category with demand tied to an aging U.S. population rather than to more cyclical office or retail leasing trends. St. Augustine, a historic coastal city in northeast Florida with a large and growing retiree population, has drawn steady institutional interest in senior housing assets in recent years. The $54 million price for a single community - well above the roughly $20 million threshold that typically distinguishes a notable single-property deal from a routine local transaction - reflects both the scale of the 102,786-square-foot property and continued investor appetite for stabilized senior living real estate in Sun Belt retirement markets. Healthpeak's core business spans three segments: outpatient medical office buildings typically anchored by hospital systems, life-science lab space concentrated in innovation hubs like Boston and the San Francisco Bay Area, and a senior housing operating portfolio that includes assisted living and memory care communities. The company has periodically rotated capital among those segments depending on where it sees the most favorable supply-demand dynamics, and senior housing has drawn increased attention across the REIT sector as occupancy has recovered from pandemic-era lows while new construction has remained constrained by high financing and labor costs. What it means. The deal adds to a wave of capital moving into senior housing this year. Healthpeak's larger peers have been signaling similar conviction: Welltower recently raised guidance as its senior housing net operating income grew 20.5% for a 15th consecutive quarter, and Ventas raised its 2026 senior housing investment target by 50% to $4.5 billion. Healthpeak's St. Augustine purchase, while modest next to those companies' portfolio-scale commitments, fits the same pattern: large, diversified healthcare REITs are increasingly competing for individual, well-located senior living assets as demographic tailwinds from an aging population make the sector one of the more resilient corners of commercial real estate.

Brookfield-Healthpeak $2.1B deal: decoding BAM's cash-cow advantage. Brookfield Asset Management (TSX:BAM) has struck a deal with Healthpeak Properties to create a joint venture targeting outpatient medical buildings across the United States. Under the agreement, Healthpeak will hold a 51% controlling stake and act as managing member, while Brookfield and its affiliates take the remaining 49% interest. Healthpeak contributed a portfolio of 86 properties valued at approximately $2.1 billion, receiving gross proceeds of about $1.03 billion for the minority stake sale. The portfolio spans 11 states including Kentucky, Indiana, Pennsylvania, Illinois, Minnesota, New Jersey and New York, is 95% leased, and carries a weighted average remaining lease term of roughly six years. Behind the transaction, some long-term investors are paying closer attention to Brookfield Asset Management itself - a company increasingly viewed as a cash-generative compounder worth holding for decades. The investment case rests on an exceptionally clean balance sheet and sustainable shareholder returns. BAM operates with a debt-to-equity ratio of just 16.3%, leaving it virtually debt-free. Profitability metrics are equally compelling: a 71% gross margin, a 50% net margin, and a free cash flow margin as high as 57.5% all point to powerful cash generation. A 31.4% return on equity and 15.4% return on total capital further illustrate how efficiently the firm puts its capital to work. These numbers are underpinned by an asset-light, fee-based business model. With more than $1 trillion in assets under management, predominantly from institutional clients such as pension funds and governments, Brookfield enjoys a steady stream of fee-related earnings. Off the balance sheet, the firm holds $67 billion in committed but undeployed capital. Once put to work, this dry powder should meaningfully boost fee-related profits. Another durable advantage is Brookfield's deeply embedded relationship network. Situated within the broader Brookfield ecosystem, the company has access to a vast pool of potential investors, ranging from major technology companies to sovereign governments. Bruce Flatt, a senior figure at the Brookfield corporate level, does not directly oversee BAM's fund operations. Yet his connections with global political and business leaders - including meetings with Donald Trump during his presidency to discuss nuclear power projects - can indirectly assist capital-raising efforts. For income-oriented investors, BAM currently offers a dividend yield of around 4%. While the stock trades at approximately 30 times conventional earnings, the multiple based on distributable earnings - a metric that better reflects the firm's capacity to pay dividends - is markedly lower. This suggests little immediate risk to the payout. With negligible leverage, high cash conversion, and a robust fundraising pipeline, Brookfield Asset Management possesses the structural traits many look for in a multi-decade holding. The outpatient medical building deal is merely the latest footnote in a much larger investment story.